Biological products, used for human disease prevention, treatment, and diagnosis, refer to drugs prepared from microorganisms, cells, various animal and human tissues, liquids, and other biological materials obtained through ordinary or biotechnology such as genetic engineering, cell engineering, protein engineering, enzyme engineering, and protein crystallization.

Overview of Overall Market Development and Analysis of Segmented Markets

In recent years, with the intensification of population aging and changes in the disease spectrum, the demand for biological products has been increasing. For example, biological products used for the treatment of cancer, cardiovascular disease, neurodegenerative diseases, etc. will have greater market demand. According to our data, the total global market revenue for biological products in 2023 was $1167 million, and it is expected to increase to $1351 billion by 2026.

According to their different functional roles, biological products can usually be divided into three types: preventive biological products, therapeutic biological products, and diagnostic biological products. Preventive biological products refer to biological products that can enhance the body's immunity after vaccination, such as vaccines, toxoids, and antitoxins; Therapeutic biological products refer to biological products that can be used to treat certain diseases, such as various blood products, immune preparations, and gene therapy drugs; Diagnostic biological products refer to biological products used to diagnose a certain disease, such as various testing reagents, antibodies, and enzymes.

From the perspective of application sites, biological products are mainly used in hospitals, clinics, and diagnostic centers. Among them, hospitals hold the highest share.

 

Source: www.globalmarketmonitor.com

Overview of Overall Market Development and Analysis of Market Development in Major Regions

Research shows that Europe and North America are the top and second-largest revenue markets in the industry. Data shows that in 2023, the revenue of the European and North American biological product markets was $414 million and $404 million respectively, with revenue shares of 35.42% and 34.56%, respectively; The Asia Pacific market ranks third with a revenue of $256 million and market share of 21.96%.

Biological Product Market Revenue and Share by Region in 2023

Regions	Market Revenue (Million USD)	Share
North America	404	34.56%
Europe	414	35.42%
Asia Pacific	256	21.96%
South America	54	4.62%
Middle East & Africa	40	3.43%

Source: www.globalmarketmonitor.com

Market Development Trend Analysis

Innovation-driven factors:With the continuous progress of biotechnology, new biological products continue to emerge, providing a continuous source of power for market growth. In the coming years, emerging fields such as gene therapy and cell therapy will become the main driving force for market growth.

Improvement of regulatory environment:Governments around the world are strengthening the construction of regulations for biological products and raising market access barriers, which will be conducive to the standardized development of the market. Meanwhile, the strengthening of international cooperation and exchanges will also create a better external environment for market development.

Technological progress:The advancement of biotechnology provides better means for the research and production of biological products. For example, gene editing technology, cell immunotherapy technology, etc. will provide strong support for the innovation of biological products.

Cost reduction:With the expansion of production scale and technological progress, the production cost of biological products will gradually decrease, which will be conducive to further popularization and development of the market.